Simsol Medipharma Llp - Company Profile

It is a home appliances limited liability partnership based in Kandivali East, Maharashtra, India, established in 2020.
2020 Kandivali East, Maharashtra, India Active
Last Updated:
Access Report
About Simsol Medipharma Llp

Simsol Medipharma Llp, a active limited liability partnership, was established on 21 October 2020 in Kandivali East, Maharashtra, India. Engaging in repair of personal and household goods within the home appliances sector, it holds LLPIN: AAU-3536. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Bhavika Penchala (Designated Partner), Satyanarayana Rao Penchala (Designated Partner), Manga Rani Penchala (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Emp 36/804, B Wing, Bldg No.10, Uranus Chs Ltd Evershine Millenium Paradise, Sector 2A, Kandivali East, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAU-3536

  • Incorporation Date

    21 October 2020

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Simsol Medipharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Simsol Medipharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Simsol Medipharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Bhavika Penchala Designated Partner 21 Oct 2020 Current
Satyanarayana Rao Penchala Designated Partner 21 Oct 2020 Current
Manga Rani Penchala Designated Partner 21 Oct 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Simsol Medipharma Llp.

Enhance accessibility to Simsol Medipharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Simsol Medipharma Llp revenue growth over time
Simsol Medipharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Simsol Medipharma Llp?

Unlock access to Simsol Medipharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Simsol Medipharma Llp?

Unlock and access historical data on people associated with Simsol Medipharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Simsol Medipharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simsol Medipharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Simsol Medipharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Simsol Medipharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Simsol Medipharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Bhavika Penchala was appointed as a Designated Partner was appointed as a Designated Partner on 21 Oct 2020 & has been associated with this company since 5 years 3 months . was completed.

  • Director Appointment

    Satyanarayana Rao Penchala was appointed as a Designated Partner was appointed as a Designated Partner on 21 Oct 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Manga Rani Penchala was appointed as a Designated Partner was appointed as a Designated Partner on 21 Oct 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • LLP Incorporation

    Simsol Medipharma Llp was registered on 21 Oct 2020 with Roc Mumbai & aged 5 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Simsol Medipharma Llp?

The LLPIN of Simsol Medipharma Llp is AAU-3536.

Where is Simsol Medipharma Llp headquartered?

Simsol Medipharma Llp is headquartered at Emp 36/804, B Wing, Bldg No.10, Uranus Chs Ltd Evershine Millenium Paradise, Sector 2A, Kandivali East, Maharashtra, 400101.

When was Simsol Medipharma Llp incorporated?

Simsol Medipharma Llp was incorporated on 21 October 2020.

Who are the current directors of Simsol Medipharma Llp?

The current directors of Simsol Medipharma Llp are

What is the primary industry of Simsol Medipharma Llp?

The primary industry of Simsol Medipharma Llp is Home Appliances.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available